Search Results - "TEBBEN, Andrew J."

Expanding GPCR homology model binding sites via a balloon potential: A molecular dynamics refinement approach by Kimura, S. Roy, Tebben, Andrew J., Langley, David R.

“…Homology modeling of G protein‐coupled receptors is becoming a widely used tool in drug discovery. However, unrefined models built using the bovine rhodopsin…”
Get full text

Macrocycle Conformational Sampling with MacroModel by Watts, K. Shawn, Dalal, Pranav, Tebben, Andrew J, Cheney, Daniel L, Shelley, John C

“…Sampling low energy conformations of macrocycles is challenging due to the large size of many of these molecules and the constraints imposed by the macrocycle…”
Get full text

Discovery of Disubstituted Cyclohexanes as a New Class of CC Chemokine Receptor 2 Antagonists by Cherney, Robert J, Mo, Ruowei, Meyer, Dayton T, Nelson, David J, Lo, Yvonne C, Yang, Gengjie, Scherle, Peggy A, Mandlekar, Sandhya, Wasserman, Zelda R, Jezak, Heather, Solomon, Kimberly A, Tebben, Andrew J, Carter, Percy H, Decicco, Carl P

“…We describe the design, synthesis, and evaluation of novel disubstituted cyclohexanes as potent CCR2 antagonists. Exploratory SAR studies led to the…”
Get full text

Discovery of the Selective CYP17A1 Lyase Inhibitor BMS-351 for the Treatment of Prostate Cancer by Huang, Audris, Jayaraman, Lata, Fura, Aberra, Vite, Gregory D, Trainor, George L, Gottardis, Marco M, Spires, Thomas E, Spires, Vanessa M, Rizzo, Cheryl A, Obermeier, Mary T, Elzinga, Paul A, Todderud, Gordon, Fan, Yi, Newitt, John A, Beyer, Sophie M, Zhu, Yongxin, Warrack, Bethanne M, Goodenough, Angela K, Tebben, Andrew J, Doweyko, Arthur M, Gold, David L, Balog, Aaron

“…Efforts to identify a potent, reversible, nonsteroidal CYP17A1 lyase inhibitor with good selectivity over CYP17A1 hydroxylase and CYPs 11B1 and 21A2 for the…”
Get full text

Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton’s Tyrosine Kinase (BTK) by Watterson, Scott H, Liu, Qingjie, Beaudoin Bertrand, Myra, Batt, Douglas G, Li, Ling, Pattoli, Mark A, Skala, Stacey, Cheng, Lihong, Obermeier, Mary T, Moore, Robin, Yang, Zheng, Vickery, Rodney, Elzinga, Paul A, Discenza, Lorell, D’Arienzo, Celia, Gillooly, Kathleen M, Taylor, Tracy L, Pulicicchio, Claudine, Zhang, Yifan, Heimrich, Elizabeth, McIntyre, Kim W, Ruan, Qian, Westhouse, Richard A, Catlett, Ian M, Zheng, Naiyu, Chaudhry, Charu, Dai, Jun, Galella, Michael A, Tebben, Andrew J, Pokross, Matt, Li, Jianqing, Zhao, Rulin, Smith, Daniel, Rampulla, Richard, Allentoff, Alban, Wallace, Michael A, Mathur, Arvind, Salter-Cid, Luisa, Macor, John E, Carter, Percy H, Fura, Aberra, Burke, James R, Tino, Joseph A

“…Bruton’s tyrosine kinase (BTK), a non-receptor tyrosine kinase, is a member of the Tec family of kinases and is essential for B cell receptor (BCR) mediated…”
Get full text

Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe by Carter, Percy H, Liu, Rui-Qin, Foster, William R, Tamasi, Joseph A, Tebben, Andrew J, Favata, Margaret, Staal, Ada, Cvijic, Mary Ellen, French, Michele H, Dell, Vanessa, Apanovitch, Donald, Lei, Ming, Zhao, Qihong, Cunningham, Mark, Decicco, Carl P, Trzaskos, James M, Feyen, Jean H.M

“…Once-daily s.c. administration of either human parathyroid hormone (PTH)-(1-84) or recombinant human PTH-(1-34) provides for dramatic increases in bone mass in…”
Get full text

Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches by Xiao, Hai-Yun, Li, Ning, Duan, James J.-W, Jiang, Bin, Lu, Zhonghui, Ngu, Khehyong, Tino, Joseph, Kopcho, Lisa M, Lu, Hao, Chen, Jing, Tebben, Andrew J, Sheriff, Steven, Chang, ChiehYing Y, Yanchunas, Joseph, Calambur, Deepa, Gao, Mian, Shuster, David J, Susulic, Vojkan, Xie, Jenny H, Guarino, Victor R, Wu, Dauh-Rurng, Gregor, Kurt R, Goldstine, Christine B, Hynes, John, Macor, John E, Salter-Cid, Luisa, Burke, James R, Shaw, Patrick J, Dhar, T. G. Murali

“…Scaffold hopping and structure-based drug design were employed to identify substituted 4-aminoquinolines and 4-aminonaphthyridines as potent, small molecule…”
Get full text

BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate by Cherney, Robert J, Anjanappa, Prakash, Selvakumar, Kumaravel, Batt, Douglas G, Brown, Gregory D, Rose, Anne V, Vuppugalla, Ragini, Chen, Jing, Pang, Jian, Xu, Songmei, Yarde, Melissa, Tebben, Andrew J, Paidi, Venkatram Reddy, Cvijic, Mary Ellen, Mathur, Arvind, Barrish, Joel C, Mandlekar, Sandhya, Zhao, Qihong, Carter, Percy H

“…BMS-813160 (compound 3) was identified as a potent and selective CCR2/5 dual antagonist. Compound 3 displayed good permeability at pH = 7.4 in PAMPA…”
Get full text

Heterobicyclic inhibitors of transforming growth factor beta receptor I (TGFβRI) by Harikrishnan, Lalgudi S., Warrier, Jayakumar, Tebben, Andrew J., Tonukunuru, Gopikishan, Madduri, Sudhakara R., Baligar, Vishweshwaraiah, Mannoori, Raju, Seshadri, Balaji, Rahaman, Hasibur, Arunachalam, P.N., Dikundwar, Amol G., Fink, Brian E., Fargnoli, Joseph, Fereshteh, Mark, Fan, Yi, Lippy, Jonathan, Ho, Ching-Ping, Wautlet, Barri, Sheriff, Steven, Ruzanov, Max, Borzilleri, Robert M.

“…[Display omitted] The TGFβ-TGFβR signaling pathway has been reported to play a protective role in the later stages of tumorigenesis via increasing…”
Get full text

Small Molecule Reversible Inhibitors of Bruton’s Tyrosine Kinase (BTK): Structure–Activity Relationships Leading to the Identification of 7‑(2-Hydroxypropan-2-yl)-4-[2-methyl-3-(4-oxo-3,4-dihydroquinazolin-3-yl)phenyl]‑9H‑carbazole-1-carboxamide (BMS-935177) by De Lucca, George V, Shi, Qing, Liu, Qingjie, Batt, Douglas G, Beaudoin Bertrand, Myra, Rampulla, Rick, Mathur, Arvind, Discenza, Lorell, D’Arienzo, Celia, Dai, Jun, Obermeier, Mary, Vickery, Rodney, Zhang, Yingru, Yang, Zheng, Marathe, Punit, Tebben, Andrew J, Muckelbauer, Jodi K, Chang, ChiehYing J, Zhang, Huiping, Gillooly, Kathleen, Taylor, Tracy, Pattoli, Mark A, Skala, Stacey, Kukral, Daniel W, McIntyre, Kim W, Salter-Cid, Luisa, Fura, Aberra, Burke, James R, Barrish, Joel C, Carter, Percy H, Tino, Joseph A

“…Bruton’s tyrosine kinase (BTK) belongs to the TEC family of nonreceptor tyrosine kinases and plays a critical role in multiple cell types responsible for…”
Get full text

Crystal structures of apo and inhibitor-bound TGFβR2 kinase domain: insights into TGFβR isoform selectivity by Tebben, Andrew J., Ruzanov, Maxim, Gao, Mian, Xie, Dianlin, Kiefer, Susan E., Yan, Chunhong, Newitt, John A., Zhang, Liping, Kim, Kyoung, Lu, Hao, Kopcho, Lisa M., Sheriff, Steven

“…The cytokine TGF‐β modulates a number of cellular activities and plays a critical role in development, hemostasis and physiology, as well as in diseases…”
Get full text

Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton’s tyrosine kinase (BTK) and Janus kinase 2 (JAK2) by Liu, Qingjie, Batt, Douglas G., Lippy, Jonathan S., Surti, Neha, Tebben, Andrew J., Muckelbauer, Jodi K., Chen, Lin, An, Yongmi, Chang, Chiehying, Pokross, Matt, Yang, Zheng, Wang, Haiqing, Burke, James R., Carter, Percy H., Tino, Joseph A.

“…[Display omitted] Four series of disubstituted carbazole-1-carboxamides were designed and synthesised as inhibitors of Bruton’s tyrosine kinase (BTK). 4,7- and…”
Get full text

Discovery and Structure–Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1) by Gilmore, John L, Sheppeck, James E, Watterson, Scott H, Haque, Lauren, Mukhopadhyay, Parag, Tebben, Andrew J, Galella, Michael A, Shen, Ding Ren, Yarde, Melissa, Cvijic, Mary Ellen, Borowski, Virna, Gillooly, Kathleen, Taylor, Tracy, McIntyre, Kim W, Warrack, Bethanne, Levesque, Paul C, Li, Julia P, Cornelius, Georgia, D’Arienzo, Celia, Marino, Anthony, Balimane, Praveen, Salter-Cid, Luisa, Barrish, Joel C, Pitts, William J, Carter, Percy H, Xie, Jenny, Dyckman, Alaric J

“…Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid metabolite that regulates a multitude of physiological processes such as lymphocyte trafficking,…”
Get full text

Discovery of 4‑Azaindole Inhibitors of TGFβRI as Immuno-oncology Agents by Zhang, Yong, Zhao, Yufen, Tebben, Andrew J, Sheriff, Steven, Ruzanov, Max, Fereshteh, Mark P, Fan, Yi, Lippy, Jonathan, Swanson, Jesse, Ho, Ching-Ping, Wautlet, Barri S, Rose, Anne, Parrish, Karen, Yang, Zheng, Donnell, Andrew F, Zhang, Liping, Fink, Brian E, Vite, Gregory D, Augustine-Rauch, Karen, Fargnoli, Joseph, Borzilleri, Robert M

“…The multifunctional cytokine TGFβ plays a central role in regulating antitumor immunity. It has been postulated that inhibition of TGFβ signaling in concert…”
Get full text

Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads by Donnell, Andrew F., Zhang, Yong, Stang, Erik M., Wei, Donna D., Tebben, Andrew J., Perez, Heidi L., Schroeder, Gretchen M., Pan, Chin, Rao, Chetana, Borzilleri, Robert M., Vite, Gregory D., Gangwar, Sanjeev

“…[Display omitted] Macrocyclic pyrrolobenzodiazepine dimers were designed and evaluated for use as antibody-drug conjugate payloads. Initial structure–activity…”
Get full text

Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent by Velaparthi, Upender, Darne, Chetan Padmakar, Warrier, Jayakumar, Liu, Peiying, Rahaman, Hasibur, Augustine-Rauch, Karen, Parrish, Karen, Yang, Zheng, Swanson, Jesse, Brown, Jennifer, Dhar, Gopal, Anandam, Aravind, Holenarsipur, Vinay K, Palanisamy, Kamalavenkatesh, Wautlet, Barri S, Fereshteh, Mark P, Lippy, Jonathan, Tebben, Andrew J, Sheriff, Steven, Ruzanov, Max, Yan, Chunhong, Gupta, Anuradha, Gupta, Arun Kumar, Vetrichelvan, Muthalagu, Mathur, Arvind, Gelman, Marina, Singh, Rajinder, Kinsella, Todd, Murtaza, Anwar, Fargnoli, Joseph, Vite, Gregory, Borzilleri, Robert M

“…Novel imidazole-based TGFβR1 inhibitors were identified and optimized for potency, selectivity, and pharmacokinetic and physicochemical characteristics…”
Get full text

Discovery of the CCR1 Antagonist, BMS-817399, for the Treatment of Rheumatoid Arthritis by Santella, Joseph B, Gardner, Daniel S, Duncia, John V, Wu, Hong, Dhar, Murali, Cavallaro, Cullen, Tebben, Andrew J, Carter, Percy H, Barrish, Joel C, Yarde, Melissa, Briceno, Stephanie W, Cvijic, Mary Ellen, Grafstrom, R. Robert, Liu, Richard, Patel, Sima R, Watson, Andrew J, Yang, Guchen, Rose, Anne V, Vickery, Rodney D, Caceres-Cortes, Janet, Caporuscio, Christian, Camac, Daniel M, Khan, Javed A, An, Yongmi, Foster, William R, Davies, Paul, Hynes, John

“…High-affinity, functionally potent, urea-based antagonists of CCR1 have been discovered. Modulation of PXR transactivation has revealed the selective and…”
Get full text

Acyl Guanidine Inhibitors of β‑Secretase (BACE-1): Optimization of a Micromolar Hit to a Nanomolar Lead via Iterative Solid- and Solution-Phase Library Synthesis by Gerritz, Samuel W, Zhai, Weixu, Shi, Shuhao, Zhu, Shirong, Toyn, Jeremy H, Meredith, Jere E, Iben, Lawrence G, Burton, Catherine R, Albright, Charles F, Good, Andrew C, Tebben, Andrew J, Muckelbauer, Jodi K, Camac, Daniel M, Metzler, William, Cook, Lynda S, Padmanabha, Ramesh, Lentz, Kimberley A, Sofia, Michael J, Poss, Michael A, Macor, John E, Thompson, Lorin A

“…This report describes the discovery and optimization of a BACE-1 inhibitor series containing an unusual acyl guanidine chemotype that was originally…”
Get full text

Discovery of BMS-753426: A Potent Orally Bioavailable Antagonist of CC Chemokine Receptor 2 by Yang, Michael G, Xiao, Zili, Zhao, Rulin, Tebben, Andrew J, Wang, Bei, Cherney, Robert J, Batt, Douglas G, Brown, Gregory D, Cvijic, Mary Ellen, Duncia, John V, Gallela, Michael A, Gardner, Daniel S, Khandelwal, Purnima, Malley, Mary F, Pang, Jian, Rose, Anne V, Santella, Joseph B, Sarjeant, Amy A, Xu, Songmei, Mathur, Arvind, Mandlekar, Sandhya, Vuppugalla, Ragini, Zhao, Qihong, Carter, Percy H

“…To improve the metabolic stability profile of BMS-741672 (1a), we undertook a structure–activity relationship study in our trisubstituted cyclohexylamine…”
Get full text

Developing Adnectins That Target SRC Co-Activator Binding to PXR: A Structural Approach toward Understanding Promiscuity of PXR by Khan, Javed A., Camac, Daniel M., Low, Simon, Tebben, Andrew J., Wensel, David L., Wright, Martin C., Su, Julie, Jenny, Victoria, Gupta, Ruchira Das, Ruzanov, Max, Russo, Katie A., Bell, Aneka, An, Yongmi, Bryson, James W., Gao, Mian, Gambhire, Pallavi, Baldwin, Eric T., Gardner, Daniel, Cavallaro, Cullen L., Duncia, John V., Hynes, John

“…The human pregnane X receptor (PXR) is a promiscuous nuclear receptor that functions as a sensor to a wide variety of xenobiotics and regulates expression of…”
Get full text